MSB 2.70% 95.0¢ mesoblast limited

Ann: Update on Novartis Agreement, page-503

  1. 5,723 Posts.
    lightbulb Created with Sketch. 2058
    AFR article is out. Once again, they use such an unflattering photo of SI!

    https://www.copyright link/companies/healthcare-and-fitness/mesoblast-shares-tank-as-novartis-terminates-deal-20211214-p59he5

    One interesting statement from the article:

    The company also plans to initiate a Phase 3 trial that may support a European application to market its proposed stem cell-based treatment for COVID-19.

    “COVID-19 is likely to remain a serious global problem and to provide a major commercial opportunity for Mesoblast, with a steady state of intensive care unit (ICU) ARDS patients irrespective of vaccines and anti-viral treatments,” the company said.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.